DARVAC: Inserm impact Santé
Team 3 from INCIT Lab Inserm U1302 (Nantes) is part of the Inserm Impact Santé project DARVAC...
Publication date: 21 June 2022
Read also:
read more
"Deciphering the immune escape mechanism of the Epstein-Barr oncovirus and exploiting it as a therapeutic target for cancers linked to this virus".
Seminar Speaker: Marc Blondel (UBO Faculty of Medicine and Health Sciences)...
Read more articles
"Deciphering the immune escape mechanism of the Epstein-Barr oncovirus and exploiting it as a therapeutic target for cancers linked to this virus".
Dr Marc Blondel (Faculté de Médecine et des Sciences de la Santé de l'UBO (Brest), invited by Team 2, will give a seminar entitled: Decrypting the immune escape mechanism of the Epstein-Barr oncovirus and exploiting it as a therapeutic target for cancers linked to this virus, on May 14 at 11.00 - Rooms 1, 2, 3 - IRS2, Nantes.
"Regulatory T cells control inflammatory and non-inflammatory pain through endogenous opioids".
Dr Gilles Marodon (Inserm U1135 | CIMI-PARIS | SiRiC Curamus), invited by Team 3, will give a seminar entitled: Regulatory T cells control inflammatory and non-inflammatory pain through endogenous opioids , on March 14 at 11.00 - Rooms 1, 2, 3 - IRS2, Nantes
"2 prizes for Incit at the Go Immuno congress - December 11 & 12, 2023".
INCIT was honored at the "Go Immuno" conference organized by Labex IGO in December. Margaux Verdon (team 1) was awarded the prize for best poster, while Gwenann Cadiou (team 3) won the prize for best oral communication!